Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01742039 · ClinicalTrials.gov registry record
Prevention of Postoperative Atrial Fibrillation
A clinical trial, sponsored by George Washington University.
- Completed
- Registry status
- 160
- Enrollment target
NCT01742039: Completed study, sponsored by George Washington University.
NCT01742039 is a clinical trial that has completed, run by George Washington University. The registered enrollment target is 160 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01742039 has completed, sponsored by George Washington University.
- COMPLETED
- Registry status
- 160 participants
- Enrollment target
Study Summary
The primary aim of this study is to determine the safest and most effective therapeutic strategy to decrease the incidence of postoperative atrial fibrillation following cardiac surgery in an era with shorter ICU and hospital length of stay. A secondary goal is to evaluate the length of hospital stay associated with each treatment strategy.
Primary Outcome
The primary endpoint of this study was also the occurrence of atrial fibrillation for any length of time requiring treatment as a result of symptoms or hemodynamic compromise.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 160 participants |
| Start Date | 2008-07 |
| Est. Completion | 2011-06 |
What the finished NCT01742039 record still lists
NCT01742039 is an observational study that tracks outcomes without assigning an intervention. The registered 160 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT01742039 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01742039 about?
NCT01742039 is a clinical study titled "Prevention of Postoperative Atrial Fibrillation". The primary aim of this study is to determine the safest and most effective therapeutic strategy to decrease the incidence of postoperative atrial fibrillation following cardiac surgery in an era with shorter ICU and hospital length of stay. A secondary goal is to evaluate the length of hospital sta...
What is the current status of trial NCT01742039?
This trial is currently completed. The enrollment target is 160 participants. The study started on 2008-07. Estimated completion is 2011-06.
Who is sponsoring clinical trial NCT01742039?
This trial is sponsored by George Washington University, which has 133 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00501826 · 160 participants · Phase 2
Combination Chemotherapy and Nelarabine in Treating Patients With T-cell Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma
- NCT00932139 · 160 participants · NA
Effect of Electro-Acupuncture on Blood Pressure
- NCT00992901 · 160 participants · Early Phase 1
Role of Neural and Hormonal Regulation Factors on Insulin Secretion After Gastric Bypass Surgery
- NCT01515527 · 160 participants · Phase 2
Cladribine Plus Low Dose Cytarabine (LDAC) Alternating With Decitabine in Patients With Acute Myeloid Leukemia (AML) or High-Risk Myelodysplastic Syndrome (MDS)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia